Regulatory

Regulatory  ·  Weekly Digest 19 Oct to 25 Oct 2024
Adcentrx Therapeutics announces FDA clearance of Investigational New Drug Application for ADRX-0405, a potential first-in-class ADC targeting STEAP1 for the treatment of advanced solid tumors

Weekly Digest – October 2024 Weekly Digest – October 2024 21 Oct 2024: Adcentrx Therapeutics announces FDA clearance of Investigational New Drug Application for ADRX-0405, a potential first-in-class ADC targeting STEAP1 for the treatment of advanced solid tumors Adcentrx Therapeutics […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest 19 Oct to 25 Oct 2024
Gilead pulls Trodelvy’s approval in bladder cancer after trial flop, FDA discussions

Weekly Digest – October 2024 Weekly Digest – October 2024 18 Oct 2024: Gilead pulls Trodelvy’s approval in bladder cancer after trial flop, FDA discussions Gilead Sciences has announced the withdrawal of Trodelvy as a treatment for bladder cancer in […]

by Sandhya Ramalingam

Continue Reading